Zynerba Pharmaceuticals Inc. Archives

Home Tags Zynerba Pharmaceuticals Inc.

Zynerba Initiates Phase II INSPIRE Trial Of Zygel

ME Staff - May 31, 2019

Zynerba Gives Clinical Update, Lifelong Impact Of ZYN002

ME Staff - December 19, 2018

Insider Trading Activity Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) – Major Shareholder Bought...

ME Staff - May 31, 2018

Insider Trading Activity Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) – Major Shareholder Bought...

ME Staff - March 23, 2018

Insider Trading Activity Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) – Major Shareholder Bought...

ME Staff - January 3, 2018

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Files An 8-K Reports Third Quarter 2016...

ME Staff - November 14, 2016

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Files An 8-K Announces Initiation of STAR...

ME Staff - November 2, 2016

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Files An 8-K

ME Staff - October 18, 2016

/* */

EDITOR PICKS

Cannabis Stock News Daily Roundup June 11

June 11, 2019

Market Morning: US Concerned on Hong Kong, Beyond Meat Beyond Stratosphere,...

June 11, 2019

Market Morning: Hong Kong Nerves, Airless Tires, Aerospace Mergers and Brexit...

June 10, 2019

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: Zynerba Pharmaceuticals Inc.

Zynerba Initiates Phase II INSPIRE Trial Of Zygel

Zynerba Gives Clinical Update, Lifelong Impact Of ZYN002

Insider Trading Activity Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) – Major Shareholder Bought...

Insider Trading Activity Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) – Major Shareholder Bought...

Insider Trading Activity Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) – Major Shareholder Bought...

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Files An 8-K Reports Third Quarter 2016...

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Files An 8-K Announces Initiation of STAR...

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Files An 8-K

EDITOR PICKS

Cannabis Stock News Daily Roundup June 11

Market Morning: US Concerned on Hong Kong, Beyond Meat Beyond Stratosphere,...

Market Morning: Hong Kong Nerves, Airless Tires, Aerospace Mergers and Brexit...

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY